BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Uslusoy HS, Nak SG, Gülten M, Bıyıklı Z. Non-alcoholic steatohepatitis with normal aminotransferase values. World J Gastroenterol 2009; 15(15): 1863-1868 [PMID: 19370784 DOI: 10.3748/wjg.15.1863]
URL: https://www.wjgnet.com/1007-9327/full/v15/i15/1863.htm
Number Citing Articles
1
Yoshio Sumida, Masato Yoneda, Hideyuki Hyogo, Yoshito Itoh, Masafumi Ono, Hideki Fujii, Yuichiro Eguchi, Yasuaki Suzuki, Noriaki Aoki, Kazuyuki Kanemasa, Koji Fujita, Kazuaki Chayama, Toshiji Saibara, Norifumi Kawada, Kazuma Fujimoto, Yutaka Kohgo, Toshikazu Yoshikawa, Takeshi Okanoue. Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease populationBMC Gastroenterology 2012; 12(1) doi: 10.1186/1471-230X-12-2
2
Elif Ozsu, Bahadır Yazıcıoğlu. Obese boys with low concentrations of high-density lipoprotein cholesterol are at greater risk of hepatosteatosisHormones 2019; 18(4): 477 doi: 10.1007/s42000-019-00152-2
3
Mateusz Szudzik, Tomasz Hutsch, Dawid Chabowski, Mikołaj Zajdel, Marcin Ufnal. Normal caloric intake with high-fat diet induces metabolic dysfunction-associated steatotic liver disease and dyslipidemia without obesity in ratsScientific Reports 2024; 14(1) doi: 10.1038/s41598-024-74193-y
4
Tomonari Harada, Takeshi Araki, Hiroaki Sunaga, Kazuki Kagami, Kuniko Yoshida, Toshimitsu Kato, Ryo Kawakami, Junichi Tomono, Naoki Wada, Tatsuya Iso, Masahiko Kurabayashi, Masaru Obokata. Pathophysiological and diagnostic importance of fatty acid-binding protein 1 in heart failure with preserved ejection fractionScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-00760-2
5
Ankush Jajodia, Philippe Soyer, Maxime Barat, Michael N. Patlas. Imaging of hepato-pancreato-biliary emergencies in patients with cancerDiagnostic and Interventional Imaging 2023;  doi: 10.1016/j.diii.2023.11.002
6
M. V. Kruchinina, M. F. Osipenko, A. A. Shestov, M. V. Parulikova. Fatty acid composition of blood serum and erythrocyte membranes in men with steatosis and steatohepatitis with normal transaminase activitySechenov Medical Journal 2024; 15(2): 48 doi: 10.47093/2218-7332.2024.15.2.48-60
7
Qiaoli Huang, Xuying Tan, Qiongmei Wu, Hanqing Zhao, Hangjun Chen, Xinxue Yu, Jinting Wang, Xueyi Huang, Yurong Huang, Jun Wei, Feng Wu, Huilian Zhu, Lijun Wang. Lipid Accumulation Product is a Valid Predictor of Hepatic Steatosis and Nonalcoholic Fatty Liver DiseaseBiomarkers in Medicine 2024; 18(3): 123 doi: 10.2217/bmm-2023-0725
8
Molly A. Bozic, Girish Subbarao, Jean P. Molleston. Pediatric Nonalcoholic Fatty Liver DiseaseNutrition in Clinical Practice 2013; 28(4): 448 doi: 10.1177/0884533613489153
9
Matthew D. Merrell, Nathan J. Cherrington. Drug metabolism alterations in nonalcoholic fatty liver diseaseDrug Metabolism Reviews 2011; 43(3): 317 doi: 10.3109/03602532.2011.577781
10
Ilona Darlyuk-Saadon, Chen Bai, Chew Kiat Matthew Heng, Nechama Gilad, Wei-Ping Yu, Pei Yen Lim, Amaury Cazenave-Gassiot, Yongliang Zhang, W. S. Fred Wong, David Engelberg. Active p38α causes macrovesicular fatty liver in miceProceedings of the National Academy of Sciences 2021; 118(14) doi: 10.1073/pnas.2018069118
11
Yoshiaki YAJIMA, Takako SUGITA, Taketoshi SATO, Takeru MITA, Mayumi TOZUKA, Isao KUROSAWA. Ultrasound findings of fatty liver using advanced ultrasonoscope equipped with differential tissue harmonic imaging: re-evaluation of diagnostic criteria in comparison with CT findingsChoonpa Igaku 2010; 37(5): 587 doi: 10.3179/jjmu.37.587
12
Yogesh Yadav, Wing-Kin Syn, Rita Basu. Evolving Management Strategies for Nonalcoholic Fatty Liver Disease–Targeting Primary Care PhysiciansDiabetes Technology & Therapeutics 2019; 21(11): 611 doi: 10.1089/dia.2019.0158
13
Diana Zaineff Banderas, Jorge Escobedo, Evangelina Gonzalez, María Gabriela Liceaga, Jesus Cenobio Ramírez, María Guadalupe Castro. γ-Glutamyl transferaseEuropean Journal of Gastroenterology & Hepatology 2012; 24(7): 805 doi: 10.1097/MEG.0b013e328354044a
14
Jörn M. Schattenberg, Maria-Magdalena Balp, Brenda Reinhart, Andreas Tietz, Stephane A. Regnier, Gorana Capkun, Qin Ye, Jürgen Loeffler, Marcos C. Pedrosa, Matt Docherty. NASHmap: clinical utility of a machine learning model to identify patients at risk of NASH in real-world settingsScientific Reports 2023; 13(1) doi: 10.1038/s41598-023-32551-2
15
Adrian Bekier, Justyna Gatkowska, Maciej Chyb, Justyna Sokołowska, Grażyna Chwatko, Rafał Głowacki, Agata Paneth, Katarzyna Dzitko. 4-Arylthiosemicarbazide derivatives – Pharmacokinetics, toxicity and anti-Toxoplasma gondii activity in vivoEuropean Journal of Medicinal Chemistry 2022; 244: 114812 doi: 10.1016/j.ejmech.2022.114812
16
Y. Yilmaz. Review article: is non‐alcoholic fatty liver disease a spectrum, or are steatosis and non‐alcoholic steatohepatitis distinct conditions?Alimentary Pharmacology & Therapeutics 2012; 36(9): 815 doi: 10.1111/apt.12046
17
Anchalia Chandrakumaran, Mohammad Shadab Siddiqui. Implications of Nonalcoholic Steatohepatitis as the Cause of End-Stage Liver Disease Before and After Liver TransplantGastroenterology Clinics of North America 2020; 49(1): 165 doi: 10.1016/j.gtc.2019.09.005
18
Nikhil S. Patil, Natasha Larocque, Christian B. van der Pol, Carlos Torres, Demetrios A. Raptis, Michael N. Patlas. Chemotherapy-Induced Toxicities: An Imaging PrimerCanadian Association of Radiologists Journal 2023; 74(2): 432 doi: 10.1177/08465371221120263
19
Walid A. Elsherbiny, Tarek A. Besheer, Amro A. El-Karef, Ehab B. Rakha. Prognostic factors for progression of simple steatosis to steatohepatitis in patients with persistent normal and elevated liver enzymesEgyptian Liver Journal 2013; 3(4): 107 doi: 10.1097/01.ELX.0000433598.15423.a1
20
Ko Maung, Sendhilnathan Ramalingam, Mohammad Chaudhry, Yi Ren, Sin-Ho Jung, Kristi Romero, Kelly Corbet, Nelson J. Chao, Taewoong Choi, Anna Mae Diehl, Louis Diehl, Cristina Gasparetto, Mitchell Horwitz, Gwynn Douglas Long, Richard D. Lopez, David A. Rizzieri, Stefanie Sarantopoulos, Keith M. Sullivan, Mustafa R. Bashir, Anthony D. Sung, Gianfranco D. Alpini. Pre-transplant hepatic steatosis (fatty liver) is associated with chronic graft-vs-host disease but not mortalityPLOS ONE 2020; 15(9): e0238824 doi: 10.1371/journal.pone.0238824
21
Edyta Maslak, Elzbieta Buczek, Antoni Szumny, Wojciech Szczepnski, Magdalena Franczyk-Zarow, Aneta Kopec, Stefan Chlopicki, Teresa Leszczynska, Renata B. Kostogrys. Individual CLA Isomers, c9t11 and t10c12, Prevent Excess Liver Glycogen Storage and Inhibit Lipogenic Genes Expression Induced by High-Fructose Diet in RatsBioMed Research International 2015; 2015: 1 doi: 10.1155/2015/535982
22
Sandhya Narasimhan, Kuppan Gokulakrishnan, Rangasamy Sampathkumar, Syed Farooq, Radhakrishnan Ravikumar, Viswanathan Mohan, Muthuswamy Balasubramanyam. Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and without type 2 diabetesClinical Biochemistry 2010; 43(10-11): 815 doi: 10.1016/j.clinbiochem.2010.04.003
23
Maneerat Chayanupatkul, Divya B. Dasani, Kristian Sogaard, Thomas D. Schiano. The Utility of Assessing Liver Allograft Fibrosis and Steatosis Post–Liver Transplantation Using Transient Elastography With Controlled Attenuation ParameterTransplantation Proceedings 2021; 53(1): 159 doi: 10.1016/j.transproceed.2020.02.160
24
Behairy E. Behairy, Hatem M. Hussein, Elsayed I. Salama, Nermin M. Adawy, Ashraf A. Elmeery. Nonalcoholic fatty liver and steatohepatitis in obese childrenEgyptian Liver Journal 2011; 1(2): 73 doi: 10.1097/01.ELX.0000397037.56165.75
25
Emily R. Perito, Patrika M. Tsai, Sarah Hawley, Robert H. Lustig, Vickie A. Feldstein. Targeted Hepatic Sonography During Clinic Visits for Detection of Fatty Liver in Overweight ChildrenJournal of Ultrasound in Medicine 2013; 32(4): 637 doi: 10.7863/jum.2013.32.4.637
26
Mario Masarone, Valerio Rosato, Andrea Aglitti, Tommaso Bucci, Rosa Caruso, Teresa Salvatore, Ferdinando Carlo Sasso, Marie Francoise Tripodi, Marcello Persico, Patricia Aspichueta. Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damagePLOS ONE 2017; 12(6): e0178473 doi: 10.1371/journal.pone.0178473
27
Mark D. Muthiah, Arun J. Sanyal. Burden of Disease due to Nonalcoholic Fatty Liver DiseaseGastroenterology Clinics of North America 2020; 49(1): 1 doi: 10.1016/j.gtc.2019.09.007
28
Yusuf Yilmaz, Enver Dolar. Biomarkers for noninvasive biochemical diagnosis of nonalcoholic steatohepatitis: Tools or decorations?World Journal of Gastroenterology 2009; 15(34): 4346-4347 doi: 10.3748/wjg.15.4346
29
Katelynn S. Madill-Thomsen, Marwan Abouljoud, Chandra Bhati, Michał Ciszek, Magdalena Durlik, Sandy Feng, Bartosz Foroncewicz, Iman Francis, Michał Grąt, Krzysztof Jurczyk, Goran Klintmalm, Maciej Krasnodębski, Geoff McCaughan, Rosa Miquel, Aldo Montano-Loza, Dilip Moonka, Krzysztof Mucha, Marek Myślak, Leszek Pączek, Agnieszka Perkowska-Ptasińska, Grzegorz Piecha, Trevor Reichman, Alberto Sanchez-Fueyo, Olga Tronina, Marta Wawrzynowicz-Syczewska, Andrzej Więcek, Krzysztof Zieniewicz, Philip F. Halloran. The molecular phenotypes of injury, steatohepatitis, and fibrosis in liver transplant biopsies in the INTERLIVER studyAmerican Journal of Transplantation 2022; 22(3): 909 doi: 10.1111/ajt.16890
30
Josivan G. Lima, Lucia Helena C. Nobrega, Natalia Nobrega de Lima, Maria Goretti do Nascimento Santos, Maria F. P. Baracho, Selma Maria Bezerra Jeronimo. Clinical and laboratory data of a large series of patients with congenital generalized lipodystrophyDiabetology & Metabolic Syndrome 2016; 8(1) doi: 10.1186/s13098-016-0140-x
31
Federica Vernuccio, Marco Dioguardi Burgio, Filippo Barbiera, Silvestro Cusmà, Giuseppe Badalamenti, Massimo Midiri, Valérie Vilgrain, Giuseppe Brancatelli. CT and MR imaging of chemotherapy-induced hepatopathyAbdominal Radiology 2019; 44(10): 3312 doi: 10.1007/s00261-019-02193-y
32
Karuna Rasineni, Daniel D. Penrice, Sathish Kumar Natarajan, Mark A. McNiven, Benita L. McVicker, Kusum K. Kharbanda, Carol A. Casey, Edward N. Harris. Alcoholic vs non-alcoholic fatty liver in rats: distinct differences in endocytosis and vesicle trafficking despite similar pathologyBMC Gastroenterology 2016; 16(1) doi: 10.1186/s12876-016-0433-4
33
Thomas Jensen, Amanda Wieland, Melanie Cree-Green, Kristen Nadeau, Shelby Sullivan. Clinical workup of fatty liver for the primary care providerPostgraduate Medicine 2019; 131(1): 19 doi: 10.1080/00325481.2019.1546532
34
Hiroyuki Kanamori, Yukiomi Nakade, Taeko Yamauchi, Kazumasa Sakamoto, Tadahisa Inoue, Takaya Yamamoto, Yuji Kobayashi, Norimitsu Ishii, Tomohiko Ohashi, Kiyoaki Ito, Yoshio Sumida, Haruhisa Nakao, Yoshitaka Fukuzawa, Masashi Yoneda, Pavel Strnad. Influence of nicotine on choline-deficient, L-amino acid-defined diet-induced non-alcoholic steatohepatitis in ratsPLOS ONE 2017; 12(6): e0180475 doi: 10.1371/journal.pone.0180475
35
Alyaa Abusabeib, Walid El Ansari, Jassim Alobaidan, Wahiba Elhag. First Case Report of Fulminant Hepatitis After Laparoscopic Sleeve Gastrectomy Associated with Concomitant Maximal Therapeutic Dose of Acetaminophen Use, Protein Calorie Malnutrition, and Vitamins A and D, Selenium, and Glutathione DeficienciesObesity Surgery 2021; 31(2): 899 doi: 10.1007/s11695-020-04999-y
36
Safiye Mirzaii, Marjan Mansourian, Seyedeh-Masomeh Derakhshandeh-Rishehri, Roya Kelishadi, Motahar Heidari-Beni. Association of conjugated linoleic acid consumption and liver enzymes in human studies: A systematic review and meta-analysis of randomized controlled clinical trialsNutrition 2016; 32(2): 166 doi: 10.1016/j.nut.2015.08.013
37
Shunsuke Mori, Nobuyuki Arima, Masahiro Ito, Shigetoshi Fujiyama, Yasuhiro Kamo, Yukitaka Ueki, Pavel Strnad. Non-alcoholic steatohepatitis-like pattern in liver biopsy of rheumatoid arthritis patients with persistent transaminitis during low-dose methotrexate treatmentPLOS ONE 2018; 13(8): e0203084 doi: 10.1371/journal.pone.0203084
38
Katherine J.P. Schwenger, Alexander Kiu, Maryam AlAli, Amnah Alhanaee, Sandra E. Fischer, Johane P. Allard. Comparison of bioelectrical impedance analysis, mass index, and waist circumference in assessing risk for non-alcoholic steatohepatitisNutrition 2022; 93: 111491 doi: 10.1016/j.nut.2021.111491
39
M. V. Kruchinina, M. F. Osipenko, M. V. Parulikova, A. A. Gromov. Electrical and Viscoelastic Parameters of Erythrocytes as a Part of Diagnostic Models for Differentiating Fatty Liver Disease of Mixed Genesis from Non-Alcoholic and Alcohol-Related Fatty Liver DiseaseRussian Journal of Gastroenterology, Hepatology, Coloproctology 2024; 34(3): 38 doi: 10.22416/1382-4376-2024-1215-3218
40
Khalid Alswat, Faisal M Sanai, Waleed Al-hamoudi, Mona Ismail, Yaser Dahlan, Hamdan Saleh AlGhamdi, Ibrahim Altraif, Abduljaleel Alalwan, Mohamed MA Babatin, Saleh A Alqahtani. Clinical and Metabolic Characteristics of Non-Alcoholic Fatty Liver Disease Patients in Saudi Arabia: Data from the Systematic Observatory Liver Disease (SOLID) RegistryDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021; : 1167 doi: 10.2147/DMSO.S300051
41
Xuefeng Ma, Shousheng Liu, Jie Zhang, Mengzhen Dong, Yifen Wang, Mengke Wang, Yongning Xin. Proportion of NAFLD patients with normal ALT value in overall NAFLD patients: a systematic review and meta-analysisBMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-1165-z
42
Zeinab A. Elkabbany, Nancy S. Elbarbary, Eman A. Ismail, Nesrine A. Mohamed, Dina Ragab, Shereen Abdel Alem, Yasmine M. Ezzat, Sarah S. Maurice, Noha U. Hashem. Transient elastography as a noninvasive assessment tool for hepatopathies of different etiology in pediatric type 1 diabetes mellitusJournal of Diabetes and its Complications 2017; 31(1): 186 doi: 10.1016/j.jdiacomp.2016.09.009
43
Rodrigo Bremer Nones, Cláudia Pontes Ivantes, Maria Lucia Alves Pedroso. Can FIB4 and NAFLD fibrosis scores help endocrinologists refer patients with non-alcoholic fat liver disease to a hepatologist?Archives of Endocrinology and Metabolism 2017; 61(3): 276 doi: 10.1590/2359-3997000000233
44
Assim A. Alfadda, Suphia M. Sherbeeni, Adel N. Alqutub, Abdullah S. Aldosary, Nasser M. Aldaghri, Simon D. Taylor-Robinson, Saleh A. Alqahtani, Rukhsana Gul, Abdulrahman M. Almaghamsi. Transient elastography for the prevalence of non-alcoholic fatty liver disease in patients with type 2 diabetesSaudi Journal of Gastroenterology 2022; 28(6): 426 doi: 10.4103/sjg.sjg_73_22
45
R Christopher Harmon, Dina G Tiniakos, Curtis K Argo. Inflammation in nonalcoholic steatohepatitisExpert Review of Gastroenterology & Hepatology 2011; 5(2): 189 doi: 10.1586/egh.11.21
46
Y. Sumida, T. Yoshikawa, S. Tanaka, H. Taketani, K. Kanemasa, T. Nishimura, K. Yamaguchi, H. Mitsuyoshi, K. Yasui, M. Minami, Y. Naito, Y. Itoh. The 'donations for decreased ALT (D4D)' prosocial behavior incentive scheme for NAFLD patientsJournal of Public Health 2014; 36(4): 629 doi: 10.1093/pubmed/fdt098
47
Peter Makovicky, Eva Tumova, Zdenek Volek, Pavol Makovicky, Ludmila Vodickova, Jana Slyskova, Miroslav Svoboda, Alexandra Rejhova, Pavel Vodicka, Gabriel Samasca, Alena Kralova, Melinda Nagy, Marta Mydlarova-Blascakova, Jana Poracova. Histopathological aspects of liver under variable food restriction: Has the intense one-week food restriction a protective effect on non-alcoholic-fatty-liver-disease (NAFLD) development?Pathology - Research and Practice 2014; 210(12): 855 doi: 10.1016/j.prp.2014.08.007
48
Renata B. Kostogrys, Magdalena Franczyk-Żarów, Edyta Maślak, Kinga Topolska. Effect of low carbohydrate high protein (LCHP) diet on lipid metabolism, liver and kidney function in ratsEnvironmental Toxicology and Pharmacology 2015; 39(2): 713 doi: 10.1016/j.etap.2015.01.008
49
Yoshio Sumida, Yuichiro Eguchi, Masafumi Ono. Current status and agenda in the diagnosis of nonalcoholic steatohepatitis in JapanWorld Journal of Hepatology 2010; 2(10): 374-383 doi: 10.4254/wjh.v2.i10.374
50
Yuan Wu, Jing Zhou, Jun Zhang, Hongshan Li. Cytokeratin 18 in nonalcoholic fatty liver disease: value and applicationExpert Review of Molecular Diagnostics 2024; : 1 doi: 10.1080/14737159.2024.2413941
51
O. J. Kolawole, M. M. Oje, O. A. Betiku, O. Ijarotimi, O. Adekanle, D. A. Ndububa. Correlation of alanine aminotransferase levels and a histological diagnosis of steatohepatitis with ultrasound-diagnosed metabolic-associated fatty liver disease in patients from a centre in NigeriaBMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03237-4
52
Geoffrey C. Farrell, Arthur J. McCullough, Christopher P. Day. Non‐Alcoholic Fatty Liver Disease2013; : 1 doi: 10.1002/9781118556153.ch1
53
Huseyin Korkmaz, Gülhan K. Unler, Huseyin S. Gokturk, Wolfgang E. Schmidt, Levent Kebapcilar. Noninvasive estimation of disease activity and liver fibrosis in nonalcoholic fatty liver disease using anthropometric and biochemical characteristics, including insulin, insulin resistance, and 13C-methionine breath testEuropean Journal of Gastroenterology & Hepatology 2015; 27(10): 1137 doi: 10.1097/MEG.0000000000000407